Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells

Erstveröffentlichung
2022
Authors
Nilson, Robin
Lübbers, Olivia
Schmidt, Christoph Q.
Rojewski, Markus
Zeplin, Philip Helge
et al.
Wissenschaftlicher Artikel


Published in
Molecular Therapy - Methods and Clinical Development ; 25 (2022). - S. 96-110. - eISSN 2329-0501
Link to publication
https://dx.doi.org/10.1016/j.omtm.2022.03.004
Institutions
UKU. Abteilung für Gentherapie
UKU. Institut für Naturheilkunde und Klinische Pharmakologie
UKU. Institut für Transfusionsmedizin
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
EU Project uulm
ADIPOA2 / Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis / EC / H2020 / 643809
Subject headings
[Free subject headings]: COAGULATION-FACTOR X | STEM-CELLS | NEUTRALIZING ANTIBODIES | GENERATION ADENOVIRUS | INTERNATIONAL-SOCIETY | ONCOLYTIC VIROTHERAPY | GENE-TRANSFER | BINDING SITE | IDENTIFICATION | RECEPTOR
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record